• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化纳米和微米颗粒以调节免疫。

Engineering nano- and microparticles to tune immunity.

机构信息

Dept. of Materials Science and Eng., Massachusetts Institute of Technology-MIT, Cambridge, MA, USA.

出版信息

Adv Mater. 2012 Jul 24;24(28):3724-46. doi: 10.1002/adma.201200446. Epub 2012 May 29.

DOI:10.1002/adma.201200446
PMID:22641380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3786137/
Abstract

The immune system can be a cure or cause of disease, fulfilling a protective role in attacking cancer or pathogenic microbes but also causing tissue destruction in autoimmune disorders. Thus, therapies aimed to amplify or suppress immune reactions are of great interest. However, the complex regulation of the immune system, coupled with the potential systemic side effects associated with traditional systemic drug therapies, has presented a major hurdle for the development of successful immunotherapies. Recent progress in the design of synthetic micro- and nano-particles that can target drugs, deliver imaging agents, or stimulate immune cells directly through their physical and chemical properties is leading to new approaches to deliver vaccines, promote immune responses against tumors, and suppress autoimmunity. In addition, novel strategies, such as the use of particle-laden immune cells as living targeting agents for drugs, are providing exciting new approaches for immunotherapy. This progress report describes recent advances in the design of micro- and nano-particles for immunotherapies and diagnostics.

摘要

免疫系统可以是疾病的治疗者或病因,在攻击癌症或病原微生物方面发挥保护作用,但也会在自身免疫性疾病中导致组织破坏。因此,旨在放大或抑制免疫反应的疗法引起了极大的兴趣。然而,免疫系统的复杂调节,加上与传统全身药物治疗相关的潜在全身副作用,给成功的免疫疗法的发展带来了重大障碍。最近在设计可以通过物理和化学性质直接靶向药物、输送成像剂或刺激免疫细胞的合成微纳米粒子方面取得的进展,为疫苗的输送、促进针对肿瘤的免疫反应和抑制自身免疫提供了新的方法。此外,使用载药免疫细胞作为药物的靶向载体等新策略为免疫疗法提供了令人兴奋的新方法。本进展报告描述了用于免疫治疗和诊断的微纳米粒子设计的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/e64fd048bdf0/nihms513485f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/5f1cf3657b5a/nihms513485f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/c0528d18390e/nihms513485f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/fd021744bc65/nihms513485f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/b3473b62a434/nihms513485f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/0cab34ed2f59/nihms513485f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/b868e3e85fae/nihms513485f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/fd48cd462f6b/nihms513485f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/48c6f8bbe2d7/nihms513485f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/e64fd048bdf0/nihms513485f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/5f1cf3657b5a/nihms513485f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/c0528d18390e/nihms513485f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/fd021744bc65/nihms513485f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/b3473b62a434/nihms513485f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/0cab34ed2f59/nihms513485f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/b868e3e85fae/nihms513485f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/fd48cd462f6b/nihms513485f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/48c6f8bbe2d7/nihms513485f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236d/3786137/e64fd048bdf0/nihms513485f9.jpg

相似文献

1
Engineering nano- and microparticles to tune immunity.工程化纳米和微米颗粒以调节免疫。
Adv Mater. 2012 Jul 24;24(28):3724-46. doi: 10.1002/adma.201200446. Epub 2012 May 29.
2
Engineering the immune system with particles, step-by-step.用粒子逐步构建免疫系统。
Mol Immunol. 2018 Jun;98:25-27. doi: 10.1016/j.molimm.2018.02.015. Epub 2018 Mar 9.
3
Nanoscale artificial antigen presenting cells for cancer immunotherapy.用于癌症免疫治疗的纳米级人工抗原呈递细胞。
Mol Immunol. 2018 Jun;98:13-18. doi: 10.1016/j.molimm.2018.02.016. Epub 2018 Mar 7.
4
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines.探索免疫纳米关联:肿瘤疫苗的范式转变
Biomed Pharmacother. 2025 Mar;184:117897. doi: 10.1016/j.biopha.2025.117897. Epub 2025 Feb 7.
5
Biomaterial Strategies for Immunomodulation.免疫调节的生物材料策略
Annu Rev Biomed Eng. 2015;17:317-49. doi: 10.1146/annurev-bioeng-071813-104814. Epub 2015 Sep 29.
6
Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.基于纳米技术的树突状细胞操控用于增强免疫治疗策略。
Nanomedicine. 2010 Aug;6(4):523-9. doi: 10.1016/j.nano.2010.01.001. Epub 2010 Jan 18.
7
Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8 T Cell Memory and Delayed Tumor Progression.聚酸酐纳米粒子诱导低炎症性树突状细胞激活,导致 CD8 T 细胞记忆和肿瘤进展延迟。
Int J Nanomedicine. 2020 Sep 7;15:6579-6592. doi: 10.2147/IJN.S261041. eCollection 2020.
8
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.用纳米颗粒 PLGA 癌症疫苗制剂靶向树突状细胞。
Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):943-55. doi: 10.1016/j.addr.2011.05.021. Epub 2011 Jun 6.
9
Preclinical models and technologies to advance nanovaccine development.推进纳米疫苗研发的临床前模型和技术。
Adv Drug Deliv Rev. 2021 May;172:148-182. doi: 10.1016/j.addr.2021.03.001. Epub 2021 Mar 9.
10
Gold nanoparticle mediated cancer immunotherapy.金纳米颗粒介导的癌症免疫疗法。
Nanomedicine. 2014 Apr;10(3):503-14. doi: 10.1016/j.nano.2013.09.011. Epub 2013 Oct 5.

引用本文的文献

1
Synthetic organic materials for targeting immunotherapies to lymph nodes.用于将免疫疗法靶向淋巴结的合成有机材料。
Chem Mater. 2024 Oct 8;36(19):9031-9045. doi: 10.1021/acs.chemmater.4c00947. Epub 2024 Aug 30.
2
Advances in cancer nanovaccines: a focus on colorectal cancer.癌症纳米疫苗的进展:聚焦于结直肠癌
Nanomedicine (Lond). 2025 May;20(9):1029-1041. doi: 10.1080/17435889.2025.2486930. Epub 2025 Apr 5.
3
From Edmonton to Lantidra and beyond: immunoengineering islet transplantation to cure type 1 diabetes.从埃德蒙顿到兰蒂德拉,乃至更远:免疫工程胰岛移植治愈1型糖尿病。

本文引用的文献

1
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.用纳米颗粒疫苗增强对疟疾抗原的体液反应,该疫苗可扩增滤泡辅助性 T 细胞并促进生发中心诱导。
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1080-5. doi: 10.1073/pnas.1112648109. Epub 2012 Jan 12.
2
Cancer immunotherapy comes of age.癌症免疫疗法崭露头角。
Nature. 2011 Dec 21;480(7378):480-9. doi: 10.1038/nature10673.
3
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.
Front Transplant. 2025 Mar 20;4:1514956. doi: 10.3389/frtra.2025.1514956. eCollection 2025.
4
Emerging strategies in lymph node-targeted nano-delivery systems for tumor immunotherapy.用于肿瘤免疫治疗的淋巴结靶向纳米递送系统的新兴策略。
Essays Biochem. 2025 Mar 28;69(2):EBC20253008. doi: 10.1042/EBC20253008.
5
Revolutionizing Nanovaccines: A New Era of Immunization.变革性纳米疫苗:免疫接种的新时代。
Vaccines (Basel). 2025 Jan 27;13(2):126. doi: 10.3390/vaccines13020126.
6
Advancements in Nanoparticle-Based Adjuvants for Enhanced Tuberculosis Vaccination: A Review.基于纳米颗粒的佐剂在增强结核病疫苗接种方面的进展:综述
Vaccines (Basel). 2024 Nov 27;12(12):1335. doi: 10.3390/vaccines12121335.
7
Immunoprotective effect of chitosan nanoparticles with different particle sizes against H9N2 avian influenza infection.不同粒径壳聚糖纳米颗粒对H9N2禽流感感染的免疫保护作用
Poult Sci. 2025 Jan;104(1):104559. doi: 10.1016/j.psj.2024.104559. Epub 2024 Nov 22.
8
Inorganic Nanoparticle Functionalization Strategies in Immunotherapeutic Applications.免疫治疗应用中的无机纳米颗粒功能化策略
Biomater Res. 2024 Sep 25;28:0086. doi: 10.34133/bmr.0086. eCollection 2024.
9
PH-Triggered, Lymph Node Focused Immunodrug Release by Polymeric 2-Propionic-3-Methyl-maleic Anhydrides with Cholesteryl End Groups.具有胆固醇端基的聚2-丙基-3-甲基马来酸酐引发的、淋巴结靶向免疫药物释放
Adv Healthc Mater. 2024 Dec;13(32):e2402875. doi: 10.1002/adhm.202402875. Epub 2024 Sep 23.
10
Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches.揭示肠道微生物群的治疗特性:将癌症免疫疗法从基础研究转化为临床应用。
Med Oncol. 2024 Jun 14;41(7):175. doi: 10.1007/s12032-024-02416-3.
原位接种 TLR9 激动剂联合放疗治疗蕈样肉芽肿:一项 1/2 期研究。
Blood. 2012 Jan 12;119(2):355-63. doi: 10.1182/blood-2011-05-355222. Epub 2011 Nov 1.
4
Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells.通过树突状细胞局部调节 CTLA-4 和 GITR 增强抗肿瘤免疫。
Eur J Immunol. 2011 Dec;41(12):3553-63. doi: 10.1002/eji.201141383. Epub 2011 Oct 26.
5
From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.从干细胞到红细胞:多种蛋白质、RNA 和染色质修饰在多个层面上调节红细胞生成。
Blood. 2011 Dec 8;118(24):6258-68. doi: 10.1182/blood-2011-07-356006. Epub 2011 Oct 12.
6
Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination.抗原呈递细胞的直接激活对于 CD8+ T 细胞的启动和肿瘤疫苗接种是必需的。
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17414-9. doi: 10.1073/pnas.1108945108. Epub 2011 Oct 10.
7
Therapeutic siRNA silencing in inflammatory monocytes in mice.在小鼠的炎症单核细胞中进行治疗性 siRNA 沉默。
Nat Biotechnol. 2011 Oct 9;29(11):1005-10. doi: 10.1038/nbt.1989.
8
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.纳米颗粒偶联抗原增强肺部疫苗接种中的细胞毒性 T 细胞反应。
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):E989-97. doi: 10.1073/pnas.1104264108. Epub 2011 Oct 3.
9
Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response.α-氧化铝纳米颗粒诱导有效的自噬依赖性交叉呈递和有效的抗肿瘤反应。
Nat Nanotechnol. 2011 Sep 18;6(10):645-50. doi: 10.1038/nnano.2011.153.
10
Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis.脂质体包封糖皮质激素改变了它们在治疗实验性自身免疫性脑脊髓炎中的作用模式。
J Immunol. 2011 Oct 15;187(8):4310-8. doi: 10.4049/jimmunol.1101604. Epub 2011 Sep 14.